Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
International Journal of Medicinal Mushrooms
Facteur d'impact: 1.423 Facteur d'impact sur 5 ans: 1.525 SJR: 0.431 SNIP: 0.716 CiteScore™: 2.6

ISSN Imprimer: 1521-9437
ISSN En ligne: 1940-4344

Volume 22, 2020 Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v15.i5.40
pages 457-470

Inhibitory Effect of Ethyl Acetate Extract of the Shaggy Inc Cap Medicinal Mushroom, Coprinus comatus (Higher Basidiomycetes) Fruit Bodies on Cell Growth of Human Ovarian Cancer

Amal Rouhana-Toubi
Department of Evolutionary and Environmental Biology and Institute of Evolution, University of Haifa, Mount Carmel, Israel; Department of Biotechnology Engineering, ORT Braude College, Karmiel, Israel
Solomon P. Wasser
International Centre for Biotechnology and Biodiversity of Fungi Institute of Evolution and Faculty of Natural Sciences University of Haifa, Mt. Carmel, Haifa 31905, Israel
Abed Agbarya
Oncology Department, Rambam Health Care Campus, Bnai Zion Medical Center, Haifa, Israel
Fuad Fares
Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Mount Carmel, Israel; Department of Molecular Genetics, Carmel Medical Center, Mount Carmel, Haifa, Israel


In a previous study, we screened organic extracts of different mushroom mycelia and picked ethyl acetate extract of Coprinus comatus as one of the most active extracts against human ovarian cancer cells. In the current study, we extracted a dry powder of C. comatus fruit bodies using ethyl acetate and examined its effect on the viability of three cell lines originated from human ovarian cancer (ES-2, SKOV-3, and SW-626). This extract was active against all tested cell lines, in a dose-dependent manner (concentrations 50−200 µg/mL, P<0.01). In an attempt to segregate the active fraction, we subjected the extract to chromatography on a silica gel column. The effect of six different fractions and of the crude extract on the viability of ES-2 cells was examined after exposure time of 24 h. Fraction F (last eluted) was significantly more effective than crude extract in the reduction of cell viability (P<0.01). Fraction F was also significantly more active than crude extract in the reduction of viability of SKOV-3 cells. We next identified some of the compounds of fraction F (mainly fatty acids) by gas chromatography−mass spectrometry. In summary, ethyl acetate extract of C. comatus reduced viability of three lines of human ovarian cancer. Fractionation of this extract by a silica gel column enabled the selection of a fraction significantly more active than the original extract.

Articles with similar content:

Ethyl Acetate Extracts of Submerged Cultured Mycelium of Higher Basidiomycetes Mushrooms Inhibit Human Ovarian Cancer Cell Growth
International Journal of Medicinal Mushrooms, Vol.11, 2009, issue 1
Solomon P. Wasser, Amal Rouhana-Toubi, Fuad Fares
Hypoglycemic Activity of Polysaccharide from Fruiting Bodies of the Shaggy Ink Cap Medicinal Mushroom, Coprinus comatus (Higher Basidiomycetes), on Mice Induced by Alloxan and Its Potential Mechanism
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 10
Yanfang Liu, Yan Yang, Jingsong Zhang, Shuai Zhou, Qingjiu Tang
Antibacterial and Anti-Inflammatory Activities of Mycelia of a Medicinal Mushroom from Taiwan, Taiwanofungus salmoneus (Higher Basidiomycetes)
International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 1
Shen-Shih Chiang, Jeng-Leun Mau, Shin-Yu Chen, Li-Ting Wang
Anti-MRSA Compounds from Hericium erinaceus (Bull.:Fr.) Pers.
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Hirokazu Kawagishi
Novel Bioactive Wild Medicinal Mushroom−Xylaria sp. R006 (Ascomycetes) against Multidrug Resistant Human Bacterial Pathogens and Human Cancer Cell Lines
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 10
Thangarajan Durai Anand, Karnewar Santosh, Veluchamy Ramesh, Srigiridhar Kotamraju, Chandran Karunakaran, Vellasamy Shanmugaiah, Ayyappan Rajendran